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Summary
The study objectives were to examine the association of maternal haemo-
globin with stillbirth and perinatal death in a multi-ethnic population in
England. We conducted a retrospective cohort analysis using anonymised
maternity data from 14 001 women with singleton pregnancies ≥24 weeks’
gestation giving birth between 2013 and 2015 in two hospitals - the Royal
Wolverhampton NHS Trust and Guy’s and St Thomas’ NHS Foundation
Trust. Multivariable logistic regression analyses were undertaken to analyse
the associations between maternal haemoglobin at first visit and at
28 weeks with stillbirth and perinatal death, adjusting for 11 other risk fac-
tors. Results showed that 46% of the study population had anaemia (hae-
moglobin <110 g/l) at some point during their pregnancy. The risk of
stillbirth and perinatal death decreased linearly per unit increase in haemo-
globin concentration at first visit (adjusted odds ratio [aOR] still-
birth = 070, 95% confidence interval [CI] 058–085, aOR perinatal
death = 071, 95% CI 060–084) and at 28 weeks (aOR stillbirth = 083,
95% CI 066–104; aOR perinatal death = 086, 95%CI 067–112). Com-
pared with women with haemoglobin ≥110 g/l, the risk of stillbirth and
perinatal death was five- and three-fold higher in women with moderate-
severe anaemia (haemoglobin <100 g/l) at first visit and 28 weeks, respec-
tively. These findings have clinical and public health importance.
Keywords: haemoglobin concentration, pregnancy, stillbirth, perinatal
death, maternal anaemia.
There is increasing acceptance that anaemia affects patient
outcomes. Pre-operative anaemia has an adverse impact on
surgical outcomes, and this has driven changes in patient
care pathways to attempt optimisation of a patient’s haemo-
globin before surgery (Musallam et al, 2011). Anaemia is also
highly prevalent in pregnancy, and is by far most commonly
caused by iron deficiency. Arguably, a lack of clarity on the
full clinical consequences of anaemia has contributed to the
lack of a comprehensive systematic approach to address this
public health issue during pregnancy. One recent study in
the UK showed that 24% of women developed anaemia at
some point during their pregnancy (Barroso et al, 2011). A
systematic review of 48 randomised controlled trials and 44
cohort studies provided evidence about the benefits of rou-
tine iron supplementation for selected outcomes, including
improving maternal haemoglobin concentration and child
birth-weight, but there was considerable uncertainty about
the magnitude of the effects on most other maternal and
infant outcomes including stillbirth and perinatal death due
to a lack of studies (Haider et al, 2013).
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It is thought that most stillbirths are preventable and the
causes are considered to be inextricably linked with the
health of the mother (Frøen et al, 2016). In the UK, 3252
babies were stillborn in 2014, giving an incidence of 416 per
1000 total births (Manktelow et al, 2016). The stillbirth rate
in the UK appears high compared with other high income
countries (Lawn et al, 2016). One potential aetiological factor
in the cause of stillbirth is iron deficiency anaemia, however,
there is discussion in the literature about the strength of data
supporting any association between haemoglobin concentra-
tion and stillbirth or levels of evidence on the effects of iron
supplementation (Lawn et al, 2011).
The objective of this study was to further examine the
association of maternal haemoglobin concentration at first
antenatal visit and at 28 weeks with stillbirth and perinatal
death by using very recent maternity data from large multi-
ethnic populations at two urban hospitals in England.
Methods
We conducted a retrospective cohort analysis using anon-
ymised maternity data from 14 001 women with singleton
pregnancies ≥24 weeks of gestation giving birth in two hospi-
tals between 2013 and 2015 (7175 from Royal Wolverhamp-
ton NHS Trust, 2013–2014 and 6826 from Guy’s and St
Thomas’ NHS Foundation Trust, 2014–2015). We examined
the association between maternal haemoglobin and both still-
birth and perinatal death. These two outcomes clearly over-
lap, perinatal death being a composite of stillbirths and
neonatal deaths in the first 7 days of life. However, both are
frequently used as outcome measures.
Information on infant outcomes, live-birth, stillbirth at or
after 24+0 weeks’ gestation, and neonatal death in the first
week of life were used to generate the outcome variables
‘stillbirth’ and ‘perinatal death’. Information on maternal
haemoglobin concentration at first visit and at 28 weeks was
extracted from the hospital pathology systems and then
paired with the maternity data. The datasets were then anon-
ymised. We tested this exposure variable for deviations from
linearity by fitting functional polynomials in the univariable
logistic regression models with multiple transformations of
the continuous variable (Royston et al, 1999). Results did
not show the presence of any significant non-linear associa-
tions between maternal haemoglobin and the outcomes. We
therefore used maternal haemoglobin as a continuous vari-
able for the analysis.
Other known risk factors for stillbirth and perinatal mor-
tality are advanced maternal age (>35 years), low socioeco-
nomic status, ethnicity, high body mass index (BMI),
nulliparity, smoking, antepartum haemorrhage, gestational
diabetes, maternal infection and pregnancy-induced hyper-
tensive disorders during the index pregnancy, pre-existing
diabetes mellitus, and other pre-existing medical co-morbid-
ities (such as mental health problems, hypertension, haemo-
globinopathies), placental dysfunction, fetal growth
restriction and spontaneous preterm labour (Di Mario et al,
2007; Flenady et al, 2011; Lawn et al, 2016). Major con-
founders identified from the literature include hypertensive
disorders of pregnancy, which are associated with a
decreased plasma volume and therefore a relatively higher
haemoglobin concentration, antepartum haemorrhage,
which can lead to a fall in haemoglobin, low socioeconomic
status, which could result in a low haemoglobin from poor
nutrition, and other medical comorbidities, such as haemo-
globinopathies (Di Mario et al, 2007; Flenady et al, 2011;
Lawn et al, 2016).
Information on socio-demographic characteristics, obstet-
ric history, current pregnancy problems, and medical
co-morbidities were used to generate variables for potential
confounders and other risk factors for stillbirth and perinatal
death. Information on ethnicity was not available for about
16% of the study sample. In another study Knight et al
(2009) included women with unknown ethnicity in the
‘white’ group because the re-distributed proportions matched
more accurately with the estimated ethnic profiles in the UK
population census (NHS England, 2006). The same was done
in this study. Tests for deviations from linearity showed that
maternal age had a linear association with the outcomes, but
a non-linear association was observed for maternal BMI.
Women were therefore divided into four standard groups: nor-
mal (185–249 kg/m2), underweight (<185 kg/m2), over-
weight (25-299 kg/m2) and obese (≥30 kg/m2). Parity was
used as a continuous variable and women were divided into
smokers and non-smokers based on their smoking status at
booking.
Maternal records relating to problems during the index
pregnancy were used to generate binary variables for antepar-
tum haemorrhage, gestational diabetes and hypertensive dis-
orders of pregnancy. Three binary variables were generated
from the history of medical co-morbidities; pre-existing hae-
moglobinopathies, pre-existing diabetes mellitus and any
other medical comorbidities (excluding obesity).
Statistical analysis
We compared the characteristics of the study population
with that of the general pregnant population in England
using available data on maternal characteristics from the
Hospital Episode Statistics (HES) database of the Health
and Social Care Information Centre (HSCIC) [http://www.
hscic.gov.uk/hes (Accessed 12 August 2015)]. We then
undertook univariable analysis to examine the crude associ-
ations of the outcomes (stillbirth and perinatal death) with
maternal haemoglobin concentration at first visit, usually in
the first trimester, and at 28 weeks’ gestation. Both these
time points coincide with routine haematology measure-
ments during pregnancy. Multivariable logistic regression
models were built to analyse the association of maternal
haemoglobin concentration with stillbirth and perinatal
death separately for the first visit and at 28 weeks adjusting
M. Nair et al
830 ª 2017 The Authors. British Journal of Haematology published by John Wiley & Sons Ltd.
British Journal of Haematology, 2017, 179, 829–837
for 11 other risk factors (maternal age, ethnicity, BMI,
parity, smoking status, gestational diabetes, antepartum
haemorrhage and hypertensive disorders of pregnancy, pre-
existing diabetes mellitus, haemoglobinopathies, and other
medical comorbidities). We did not find any significant
moderate to strong correlations among the independent
variables. However haemoglobin concentrations at first visit
and at 28 weeks were highly correlated (correlation coeffi-
cient 054, P < 0001), hence we did not adjust for baseline
haemoglobin status in the 28 weeks multivariable model.
Studies have shown that maternal haemoglobin concentra-
tion is associated with fetal growth restriction and preterm
birth, precursors for stillbirth and early neonatal mortality
(Haider et al, 2013; Nair et al, 2016a). Therefore, fetal
growth restriction and preterm birth were not included in
the regression models.
Additional logistic regression analyses were conducted by
dividing the women into categories of anaemia according to
their haemoglobin concentration using the cut-offs suggested
by the World Health Organisation (WHO) (no anaemia
≥110 g/l (reference group), mild anaemia 100–109 g/l; mod-
erate-severe anaemia <100 g/l) (WHO 2011). The multivari-
able models for anaemia at first visit and at 28 weeks
adjusted for the 11 other risk factors. The categorical vari-
ables for maternal anaemia at first visit and at 28 weeks were
not highly correlated, hence the 28 weeks multivariable
model also adjusted for baseline anaemia status.
We tested for plausible interactions between haemoglobin
concentration and mother’s ethnicity, and haemoglobin con-
centration and BMI by fitting interaction terms into each of
the multivariable models followed by likelihood ratio testing
(LR-test). No significant interactions were observed. Missing
information was <2% for most variables, except BMI and
smoking. Data were not assumed to be missing at random
and a proxy variable was generated by categorising the miss-
ing data as a separate group for each variable. All analyses
were performed using Stata version 131, SE (StataCorp, Col-
lege Station, TX, USA).
Sensitivity analyses
Data on index of multiple deprivation (IMD) quintiles, a
measure of socioeconomic status, was available only in the
Wolverhampton dataset, hence a sensitivity analysis was con-
ducted using this data to measure the effect of IMD quintiles
on the association between haemoglobin concentration and
the outcomes by testing two models, one with IMD quintiles
in addition to the other 11 variables and one without. The
results did not vary with the inclusion and exclusion of IMD
quintiles. Sensitivity analysis was conducted for variables with
>1% missing information by redistributing the missing
observations into the different categories of the variables; this
did not materially change the results. A complete case analy-
sis was also performed. Again the results did not differ from
the original models.
Study power
A logistic regression of the binary response variables, still-
birth and perinatal death, on a continuous variable of mater-
nal haemoglobin concentration with a fixed sample size of
14 001 observations and 04% prevalence of stillbirth in the
UK (Manktelow et al, 2016) had 80% power at a 005 signifi-
cance level to detect an odds ratio (OR) of ≤069 or ≥146
per unit increase in haemoglobin concentration. For the
anaemia analysis, the minimum sub-group sample of 279
with a prevalence range of 04% to 07% for the outcomes in
the unexposed had 80% power to detect an OR of 330 or
greater at a P-value of <005 (two-tailed), and the maximum
sub-sample 2976 for the same range of prevalence had 80%
power to detect an OR of 160 or greater at P < 005 (two-
tailed).
Results
Characteristics of the women with singleton pregnancies
delivering at or after 24+0 weeks of gestation in relation to
the study outcomes are shown in Table I. The median age of
pregnant women in the study population was 30 years (range
14–53 years) and median BMI was 25 kg/m2 (range 10–
74 kg/m2). More than a third of the pregnant women had a
BMI ≥25 kg/m2 (21% of the pregnant women were over-
weight and 17% were obese), 48% were multiparous, 13%
smoked during pregnancy and 30% belonged to ethnic
minority groups. Nearly a quarter of the women had one or
more pre-existing medical problems and 18% had problems
during the index pregnancy (04% antepartum haemorrhage,
5% gestational diabetes, 5% hypertensive disorders of preg-
nancy and approximately 7% had other problems).
In the study population, median haemoglobin concentra-
tion at first visit was 125 g/l (range 516– 191 g/l) and at
28 weeks it was 113 g/l (range 64–174 g/l). The prevalence of
mild anaemia increased, from 5% at the first visit to 22% at
28 weeks, and the proportion of women with moderate-
severe anaemia increased from 2% at first visit to 7% at
28 weeks. In 26% of the women who had a normal haemo-
globin at first visit, the concentrations decreased to <110 g/l
at 28 weeks and 23% of the women who had mild anaemia
at first visit became moderate to severely anaemic at
28 weeks. For 18% of the women with anaemia at first visit,
the haemoglobin concentrations improved to normal preg-
nancy concentrations at 28 weeks. Overall, 46% of the
women were identified to have developed anaemia at some
point during their pregnancy.
In total, 05% of singleton babies were stillborn (14 before
28 weeks of gestation and 62 after 28 completed weeks of
gestation) and a further 34 (20 of which were born before
28 weeks) died during the first seven days after birth, leading
to an overall 08% perinatal mortality rate in the study pop-
ulation. The proportions of stillbirths and perinatal deaths
did not vary across the categories of age, parity, smoking
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Table I. Characteristics of the study population in relation to the outcomes.
Maternal characteristics
(N = 14 001)
Women with live born
babies (%) n = 13 925
Women with stillborn
babies (%) n = 76
Women with infants who were
alive at seven completed days
after birth (%) n = 13 891
Women whose babies were
stillborn or died at <7 days
after birth (%) n = 110
Age (years)
<20 535 (38) 5 (66) 530 (38) 10 (91)
20–24 2,240 (161) 14 (184) 2,235 (161) 19 (173)
25–29 3,656 (263) 14 (184) 3,649 (263) 21 (191)
30–34 4,152 (298) 25 (329) 4,141 (298) 36 (327)
35–39 2,453 (176) 15 (197) 2,449 (176) 19 (173)
40–44 644 (46) 3 (40) 642 (46) 5 (45)
≥45 52 (04) 0 (0) 52 (04) 0 (0)
Missing 193 (14) 0 (0) 193 (14) 0 (0)
Parity
Nulliparous 7,231 (519) 36 (474) 7,211 (519) 56 (509)
Multiparous 6,693 (481) 40 (526) 6,679 (481) 54 (491)
Missing 1 (001) 0 (0) 1 (001) 0 (0)
Body mass index categories (kg/m2)*,†
Underweight (<185) 361 (26) 1 (13) 360 (26) 2 (18)
Normal (185–249) 4,801 (345) 23 (303) 4,788 (345) 36 (327)
Overweight (25–299) 2,978 (214) 17 (224) 2,970 (214) 25 (227)
Obese (≥30) 2,333 (167) 23 (303) 2,325 (167) 31 (282)
Missing 3,452 (248) 12 (158) 3,448 (248) 16 (146)
Smoking status
Smoker 1,808 (130) 11 (145) 1,803 (130) 16 (145)
Non-smoker 10,430 (749) 60 (789) 10,404 (749) 86 (782)
Missing 1,687 (121) 5 (66) 1,684 (121) 8 (73)
Ethnicity
White 9,722 (698) 47 (618) 9,698 (698) 71 (646)
Non-white 4,203 (302) 29 (382) 4,193 (302) 39 (354)
Problems in current pregnancy
Antepartum haemorrhage†
No 13,825 (993) 74 (974) 13,792 (993) 107 (973)
Yes 53 (04) 1 (13) 53 (04) 1 (09)
Missing 47 (03) 1 (13) 46 (03) 2 (18)
Gestational diabetes mellitus†
No 13,167 (946) 69 (908) 13,135 (946) 101 (918)
Yes 711 (51) 6 (79) 710 (51) 7 (64)
Missing 47 (03) 1 (13) 46 (03) 2 (18)
Hypertensive disorders of pregnancy†
No 13,177 (946) 69 (908) 13,147 (946) 99 (900)
Yes 694 (50) 6 (79) 691 (50) 9 (82)
Missing 54 (04) 1 (13) 53 (04) 2 (18)
Pre-existing medical problems
Diabetes mellitus*,†
No 13,693 (983) 73 (961) 13,661 (983) 105 (955)
Yes 219 (16) 2 (26) 217 (16) 4 (36)
Missing 13 (01) 1 (13) 13 (01) 1 (09)
Haemoglobinopathies*,†
No 13,832 (993) 75 (987) 13,798 (993) 109 (991)
Yes 80 (06) 0 (0) 80 (06) 0 (0)
Missing 13 (01) 1 (13) 13 (01) 1 (09)
Others (except obesity)*,†
No 11,033 (792) 52 (684) 11,009 (792) 76 (691)
Yes 2,879 (207) 23 (303) 2,869 (207) 33 (300)
Missing 13 (01) 1 (13) 13 (01) 1 (09)
*P < 005 for chi square test for difference in proportion of stillbirths across the sub-groups.
†P < 005 for chi square test for difference in proportion of perinatal deaths across the sub-groups.
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status and ethnicity, but a higher proportion of stillbirth and
perinatal death were observed among obese women and
women with pre-existing medical comorbidities (Table I).
A comparison of the study population with that of the
general population of pregnant women in England using
routine national data showed that the age distribution, and
proportions of multiparous women in the study population
were comparable with that of the general pregnant popula-
tion in England. However, the study population had a higher
proportion of women from ethnic minority groups, particu-
larly Indian, black Caribbean and black African (Table S1).
Maternal haemoglobin concentration and stillbirth
The associations between maternal haemoglobin concentra-
tion and stillbirth are shown in Table II. In singleton babies
born at or after 24+0 weeks of gestation, the crude odds of
stillbirth decreased by 25% per unit increase in the haemo-
globin concentration at first visit [OR = 075, 95% confi-
dence interval (CI) 062–092, P = 0004]. After adjusting for
11 other risk factors, the odds of stillbirth decreased by 30%
per unit increase in the haemoglobin concentration (i.e. per
10 g/l increase in haemoglobin concentration) [adjusted odds
ratio (aOR) = 070, 95% CI 058–085, P = 0001]. The asso-
ciation between maternal haemoglobin concentration at
28 weeks and stillbirth was not statistically significant at
P < 005, but an inverse linear association was observed
(OR = 086, 95% CI 065–114, P = 0277); aOR = 083,
95% CI 063–111, P = 0207).
Maternal haemoglobin concentration and perinatal death
As shown in Table II, the association between maternal hae-
moglobin concentration and perinatal death was comparable
with the association between haemoglobin concentration and
stillbirth. In singleton babies born at or after 24+0 weeks of
gestation, the crude odds of perinatal death decreased by
25% per unit increase in the haemoglobin concentration at
first visit (OR = 075, 95% CI 064–088, P = 0001). After
adjusting for the 11 risk factors, the odds of perinatal death
decreased by 29% per unit increase in the haemoglobin con-
centration (aOR = 071, 95% CI 060–084, P < 0001). The
adjusted odds of perinatal death decreased by 13% per unit
increase in haemoglobin concentration at 28 weeks, but the
association was not statistically significant at P < 005
(OR = 087, 95% CI 068–113, P = 0290; aOR = 086, 95%
CI 067–112, P = 0272).
Maternal anaemia and infant outcomes
An examination of the association between maternal anaemia
and the adverse outcomes further substantiated the results of
the inverse association between haemoglobin concentration
and the outcomes at both the first and 28 week visits. The
odds of stillbirth and perinatal death were five-fold higher
among pregnant women with moderate-severe anaemia com-
pared with women who had no anaemia at first visit
(Table III) after adjusting for the 11 other risk factors (aOR
stillbirth = 497, 95% CI 209–1179, P < 0001; aOR perina-
tal death = 516, 95% CI 253–1052, P < 0001). The odds
of stillbirth and perinatal death were more than two and a
half times higher among pregnant women with moderate-
severe anaemia at 28 weeks of gestation after adjusting for
the baseline anaemia status and 11 other risk factors com-
pared with women with normal haemoglobin concentration
at 28 weeks (aOR stillbirth = 281, 95% CI 125–630,
P = 0012; aOR perinatal death = 260, 95% CI 123–551,
P = 0012). The crude and adjusted odds ratios for stillbirth
and perinatal death among women with mild anaemia were
not significantly different compared to women who had no
anaemia at first visit (aOR stillbirth = 056, 95% CI 013–
230, P = 0416; aOR perinatal death = 058, 95% CI 018–
185, P = 0354) or at 28 weeks (aOR stillbirth = 130, 95%
CI 064–261, P = 0457; aOR perinatal death = 127, 95%
CI 068–238, P = 0446).
Discussion
This study confirms that the burden of anaemia is high:
nearly half of the women (46%) in the study population had
Table II. Association of maternal haemoglobin concentration with adverse fetal and infant outcomes.
Exposure Stillbirth Perinatal death
Maternal haemoglobin at first visit (g/l)
Unadjusted odds ratio (95% CI) per unit increase in haemoglobin concentration 075 (062–092) 075 (064–088)
Adjusted odds ratio† (95% CI) per unit increase in haemoglobin concentration 070 (058–085) 071 (060–084)
Maternal haemoglobin at 28 weeks (g/l)*
Unadjusted odds ratio (95% CI) per unit increase in haemoglobin concentration 086 (065–114) 083 (066–104)
Adjusted odds ratio† (95% CI) per unit increase in haemoglobin concentration 083 (063–111) 086 (067–112)
N = 14001 singleton babies born at or after 24 weeks of gestation.
*The model at 28 weeks excludes women who had a stillbirth or perinatal death before 28 weeks.
†Model adjusted for maternal age, body mass index, parity, smoking status, gestational diabetes, antepartum haemorrhage and pregnancy-induced
hypertension during index pregnancy, pre-existing diabetes mellitus, haemoglobinopathies, other medical comorbidities and ethnicity; CI, Confi-
dence Interval.
Association Between Maternal Haemoglobin and Stillbirth
ª 2017 The Authors. British Journal of Haematology published by John Wiley & Sons Ltd. 833
British Journal of Haematology, 2017, 179, 829–837
anaemia at some point during their pregnancy. The need for
haematologists and obstetricians to optimise local care path-
ways for recognition and management of anaemia is further
reinforced by our main study findings suggesting that the
risk of stillbirth and perinatal death decreased linearly per
unit increase in haemoglobin concentration at first visit and
at 28 weeks after accounting for 11 other known risk factors.
Compared with women with normal haemoglobin concentra-
tions, the risk of stillbirth and perinatal death was five-fold
and three-fold higher in women with moderate-severe mater-
nal anaemia at first visit and 28 weeks, respectively.
The inverse linear association of stillbirth and perinatal
death with maternal haemoglobin concentration at 28 weeks
of gestation was not statistically significant, possibly due to a
low study power, however, the higher risk of adverse out-
comes was still present among pregnant women with moder-
ate-severe anaemia (haemoglobin <100 g/l) at 28 weeks.
Overall, we believe our findings are important in the broader
haematology, obstetric and public health context as it sug-
gests that, given anaemia is most commonly related to iron
deficiency, iron supplementation during pregnancy could
have an incremental benefit on reducing the risk of stillbirth
and perinatal death for all women.
Iron deficiency anaemia during pregnancy has been
explored as a risk factor for stillbirth although the evidence
is limited and conflicting (Lawn et al, 2011). A few studies
from low-to-middle income countries have shown an associ-
ation of maternal anaemia with stillbirth and perinatal death
(Lone et al, 2004; Watson-Jones et al, 2007; Nair et al,
2016a), but others from high-income countries have not
reported a significant association (Stephansson et al, 2000;
Little et al, 2005). However, a study from the USA that used
National Maternal and Infant Health Survey data from deliv-
eries in 1988 (Tomashek et al, 2006) found a significantly
higher risk of stillbirth among non-black women who have
moderate anaemia. A prospective study from China (Zhang
et al, 2009) found that haemoglobin <90 g/l in the third tri-
mester of pregnancy was associated with a reduced risk of
stillbirth. The authors did not adjust for important preg-
nancy complications, such as hypertensive disorders of
Table III. Association of maternal anaemia with adverse infant outcomes.
Maternal anaemia
Stillbirth (n = 14001 singleton babies born at or after 24+0 of gestation)
Stillborn
(%)
Live born
(%)
Unadjusted
OR (95% CI)
P-value
for trend
†Adjusted
OR (95% CI)
P-value
for trend
First visit (Hb, g/l)
Normal Hb (≥110) 59 (776) 11 529 (828) 1 (ref) 0025 1 (ref) 0018
Mild (100–109) 2 (26) 767 (55) 051 (012–209) 056 (013–230)
Moderate-severe (<100) 6 (79) 273 (20) 429 (184–1003) 497 (209–1179)
Missing 9 (118) 1356 (97) 129 (064–262) 150 (073–311)
28 weeks (Hb, g/l)*
Normal Hb (≥110) 26 (419) 7833 (566) 1 (ref) 0008 1 (ref) 0059
Mild (100–109) 12 (194) 3007 (217) 120 (061–239) 130 (064–261)
Moderate-severe (<100) 10 (161) 988 (71) 305 (147–634) 281 (125–630)
Missing 14 (226) 2014 (146) 209 (109–402) 184 (091–374)
Maternal anaemia
Perinatal death (n = 14001 singleton babies born at or after 24+0 weeks)
Perinatal
death (%)
Alive at 7 completed
days after birth (%)
Unadjusted
OR (95% CI)
P-value
for trend
†Adjusted
OR (95% CI)
P-value
for trend
First visit (Hb, g/l)
Normal Hb (≥110) 83 (755) 11,505 (828) 1 (ref) 0003 1 (ref) 0003
Mild (100–109) 3 (27) 766 (55) 054 (017–172) 058 (018–185)
Moderate-severe (<100) 9 (82) 270 (19) 462 (229–928) 516 (253–1052)
Missing 15 (136) 1,350 (97) 154 (088–267) 185 (105–326)
28 weeks (Hb, g/l)*
Normal Hb (≥110) 32 (421) 7,827 (566) 1 (ref) 0013 1 (ref) 0059
Mild (100–109) 15 (197) 3,004 (217) 117 (067–205) 127 (068–238)
Moderate-severe (<100) 11 (145) 987 (71) 257 (137–482) 260 (123–551)
Missing 18 (237) 2,010 (145) 375 (241–584) 199 (106–371)
Hb- Haemoglobin; CI, Confidence Interval.
*Excludes 14 women with stillbirth and 34 women with perinatal death before 28 weeks.
†Model for first visit adjusted for maternal age, body mass index, parity, smoking status, gestational diabetes, antepartum haemorrhage and preg-
nancy-induced hypertension during index pregnancy, pre-existing diabetes mellitus, haemoglobinopathies, other medical comorbidities and eth-
nicity; Model for 28 weeks is adjusted for baseline anaemia status in addition to the other variables included in the first visit model.
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pregnancy, which can result in reduced plasma volume (and
thereby an increase in haemoglobin concentration). Hyper-
tensive disorders of pregnancy are known risk factors for
stillbirth with a well-recognised aetiology. These disorders,
particularly the pre-eclampsia syndrome, are associated with
a reduced maternal intravascular volume and, consequently,
a relatively higher haemoglobin concentration compared to
unaffected pregnancies. Not adjusting for these important
groups of disorders results in the potential for confounding
and bias.
A study among Swedish pregnant women found a
U-shaped association between stillbirth and haemoglobin
concentration at first visit or at 28 weeks (Stephansson et al,
2000). In contrast to our findings, the Swedish study did not
show a significant association between anaemia and stillbirth.
One possible reason for this difference could be because the
Swedish study did not account for the effect of important
risk factors for stillbirth, including gestational diabetes and
medical comorbidities; instead the multivariable models
adjusted for small-for-gestational age, which has been
hypothesised to be in the pathway mediating the effect of
haemoglobin concentration on stillbirth (Stephansson et al,
2000). Another study using data from St Mary’s Maternity
Information System database (London) did not find a signifi-
cant association between perinatal mortality and haemoglo-
bin concentration at first antenatal visit, but showed a risk
associated with lowest and highest haemoglobin concentra-
tions recorded at any point during the pregnancy after the
first visit (Little et al, 2005). A limitation of this study, as
acknowledged by the authors, was that information for hae-
moglobin concentration was missing for more than a third
of the study population. In addition, the authors did not
adjust for important potential confounders.
The present study addresses a gap in the UK to explore
evidence on the association between haemoglobin concentra-
tion and adverse fetal and infant outcomes. In addition to
the already known association of low haemoglobin during
pregnancy and maternal anaemia with poor maternal out-
comes in the UK (Nair et al, 2016b), this study identified a
significant association with stillbirth and perinatal death. The
study population appears comparable with that of the general
pregnant population in England in terms of age distribution,
multiparity and multiple pregnancies, suggesting generalis-
ability, although the study sample had a higher proportion
of women from ethnic minority groups. We did not have
information on BMI, smoking status and pregnancy prob-
lems in national data, and were unable to comment on the
comparability of these factors to the general population. We
did not have information on whether women in the study
population were taking multivitamin or iron supplementa-
tion and therefore could not account for this in the analysis.
However, according to the recommended guidance, in the
study hospitals all pregnant women who are diagnosed with
anaemia at any point during pregnancy should be prescribed
iron supplementation.
There are several limitations to recognise in our analysis.
We have defined haemoglobin thresholds during pregnancy as
commonly reported in textbooks, but it is unclear to what
degree these thresholds are validated reference ranges during
pregnancy, even allowing for the effects of changes in plasma
volume. Inability to adjust for socioeconomic status in the
main multivariable models was a limitation, but sensitivity
analysis using the Wolverhampton data did not show any sig-
nificant effect of socioeconomic status on the association we
observed between haemoglobin concentration and the out-
comes. Another limitation was missing information on hae-
moglobin concentration at first visit and at 28 weeks for about
97% and 156% of the women, respectively, which could have
biased the study results. However, the results of sensitivity
analyses by redistributing the missing observations into the
different categories of the anaemia variable, and complete case
analysis were not materially different from that of the original
models. We did not have information about the causes of still-
birth in the study population and were therefore not able to
examine the association between maternal haemoglobin and
stillbirth stratified by causes of stillbirth (for example, congeni-
tal anomalies).
Conclusion
This study provides clear evidence of an association of still-
birth and perinatal death with maternal haemoglobin con-
centration at first visit and at 28 weeks of pregnancy in a
multi-ethnic population in England. The risk of these adverse
outcomes was significantly higher among women who had
moderate-severe anaemia during pregnancy, but more
importantly, this risk decreased linearly per unit increase in
maternal haemoglobin concentration. This finding is of clini-
cal and public health importance, given that high rates of
stillbirth are a major issue globally and a high burden of
anaemia is a common finding during pregnancy.
Anaemia is most commonly caused by iron deficiency. Cur-
rent approaches to the management of anaemia during preg-
nancy are described in national guidelines (Pavord et al,
2012), based on reactive treatment following case identifica-
tion. It is of note that nearly half of women in our study popu-
lation developed anaemia at some point during their
pregnancy, which is higher than that reported several years ear-
lier in an epidemiological study (Barroso et al, 2011), suggest-
ing significant on-going challenges in delivering the current
policies for case identification and treatment. Alternative
strategies to better manage anaemia during pregnancy appear
to be an attractive option to improve maternal and fetal out-
comes, alongside attention to factors such as obesity and
smoking cessation. Routine iron supplementation during preg-
nancy can maintain normal haemoglobin concentrations and
prevent many cases of maternal anaemia. Further experimental
studies are required to investigate the effect of iron supplemen-
tation during pregnancy on fetal outcomes, assessing appropri-
ate dosing and factors such as adherence and tolerability.
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